Company profile: Syntekabio
1.1 - Company Overview
Company description
- Provider of AI drug discovery and development services based on genomic big data; a public company listed on the KOSDAQ.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Syntekabio
Unlearn
HQ: United States
Website
- Description: Provider of AI, digital twin, and statistical methods to enable smaller, more efficient clinical trials, offering TwinRCTs (RCTs enhanced with AI-generated digital twins), Digital Twin Generators to predict individual health outcomes over time, regulatory services to navigate and meet FDA and EMA guidelines, and PROCOVA using prognostic scores from digital twins to enhance statistical power.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Unlearn company profile →
Health Language
HQ: United States
Website
- Description: Provider of enterprise terminology management solutions and professional services for healthcare organizations, offering software, content, and consulting to normalize data by mapping, translating, updating, and managing clinical terminologies. Solutions include point-of-care code accuracy, data interoperability, analytics integrity, risk adjustment NLP, regulatory audit support, and consumer-friendly code descriptions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Health Language company profile →
Geospiza
HQ: United States
Website
- Description: Provider of software systems for workflow management of genetic analysis, offering GeneSifter Analysis Edition, a cloud-based data analysis product for microarray and sequencing data, and GeneSifter Lab Edition, a software platform supporting laboratory workflows.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Geospiza company profile →
Context Matters
HQ: United States
Website
- Description: Provider of a next-generation data platform linking drug development and market data, helping pharmaceutical companies access and understand complex data. Offers Cortellis Regulatory Intelligence covering global health authority requirements for human healthcare products (drugs, biologics, medical devices, IVDs) and Cortellis CMC Intelligence for CMC documentation, reducing regulatory delays and rejections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Context Matters company profile →
Indigo BioAutomation
HQ: United States
Website
- Description: Provider of automated data analysis, management, and integration solutions for clinical and life science laboratories, including ASCENT for LC-MS/MS workflows and ARQ for PCR data. Offers vendor-neutral SaaS platforms with machine learning/AI, a quality rule system applying lab SOPs across instruments, and hosted access from anywhere for flexible, efficient operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Indigo BioAutomation company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Syntekabio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Syntekabio
2.2 - Growth funds investing in similar companies to Syntekabio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Syntekabio
4.2 - Public trading comparable groups for Syntekabio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →